Nomura Raises REMEGEN TP to HKD89.44, Maintains Neutral RatingAASTOCKS News·1 day ago, 02:37 AM09995-3.24%688331-1.36%
RemeGen Deploys Idle Funds Into SPDB Wealth Products in Discloseable TransactionTip Ranks·Jul 2 at 07:38 AM688331-1.36%09995-3.24%
RemeGen Clarifies Board Composition and Committee RolesTip Ranks·Jun 16 at 09:39 AM09995-3.24%688331-1.36%
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China | VOR Stock NewsStockTitan·Jun 7 at 11:31 PM09995-3.24%688331-1.36%
Breaking! Akeso plummets 8% during trading! Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880) falls over 2.5% to set a new historical low同壁财经·Jun 1 at 08:50 PM09688-4.08%09995-3.24%
M Stanley Ratings and TPs on China Biotech StocksAASTOCKS News·May 29 at 02:32 AM688428+0.51%09969-2.70%
RemeGen Plans Governance and Articles Overhaul Following Share Incentive IssuancesTip Ranks·May 18 at 08:42 AM09995-3.24%688331-1.36%
China’s drug makers are speeding up – will AI be their secret weapon?SCMP·Apr 18 at 03:04 AM09995-3.24%688331-1.36%
Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, and many stocks including Cosunter, Rundu Pharma, Sunshine Guojian Pharmaceutical, SL PHARM, and HITECK dropping more than 6%Wallstreetcn·Apr 6 at 08:41 PM512290+1.91%002038-0.73%
Strong Growth in Innovative Drug Revenue, Biopharmaceutical Companies' Performance Shows High "Innovation" ContentWallstreetcn·Mar 29 at 05:41 PM588250+1.09%159992+1.19%
RemeGen Wins Fourth NMPA Approval for Disitamab Vedotin in HER2-Low Breast CancerTip Ranks·Mar 23 at 06:38 AM512010+1.64%159859+1.59%
Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suitWallstreetcn·Mar 16 at 09:28 PM688336-0.93%688513-1.25%
